Association of genomic characterization with clinical benefits of anti-PD-1 antibody combined with FOLFOX as neoadjuvant therapy on locally advanced gastric or gastroesophageal junction adenocarcinoma.
Ying Liu(Chongqing University), Danyang Li(Henan University of Technology), Qingxin Xia(Zhengzhou University), Chengjuan Zhang(Zhengzhou University), Baodong Li(Zhengzhou University), Hongle Li(Shanghai Jiao Tong University), Xuan Gao(Tsinghua University), Jinbang Wang(Dalian National Laboratory for Clean Energy), Guangsen Han(Zhengzhou University), Gangcheng Wang(Zhengzhou University), Jing Zhuang(Zhengzhou University), Zhi Li(Central Hospital Affiliated to Shenyang Medical College), Ke Li(Xi'an University of Science and Technology), Lei Qiao(State Key Laboratory for Innovation and Transformation of Luobing Theory), Juan Yu(Southern Medical University), Zhimeng Li(Zhengzhou University), Zhentian Liu, Shuning Xu(Zhengzhou University), Yuzhou Zhao(Capital Medical University), Gaizhen Kuang(Zhengzhou University)
Cited by 0
Related Papers
Bismuth Sulfide Nanorods as a Precision Nanomedicine for<i>in Vivo</i>Multimodal Imaging-Guided Photothermal Therapy of Tumor
|ACS Nano|2015|555
The direct electron transfer of glucose oxidase and glucose biosensor based on carbon nanotubes/chitosan matrix
|Biosensors and Bioelectronics|2005|550
The Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Directly Decimates Human Spleens and Lymph Nodes
|medRxiv|2020|387
IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor
|Nature Immunology|2021|374